Physician profile
Rodolfo Rey
NPI 1891062998
$808.70
in general payments reported to CMS, 2019-2025
14 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $13.51 · 2021: $53.79 · 2022: $77.55 · 2023: $42.32 · 2024: $219 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $179.20 | 2021-2024 | |
| Hologic Sales and Service, LLC | $132.32 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $122.26 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $100.58 | 2019-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $61.38 | 2019-2025 | |
| Astellas Pharma US INC | $60.29 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $31.27 | 2022 | |
| Roche Diagnostics Corporation | $20.60 | 2019 | |
| Medtronic, INC. | $20.38 | 2021 | |
| Smith+Nephew, INC. | $18.51 | 2024 | Pico 14 |
| Allergan, INC. | $18.49 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.33 | 2019 | |
| Lupin INC. | $13.58 | 2019 | |
| Merck Sharp & Dohme LLC | $13.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Rey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.